Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2010, Article ID 743794, 6 pages
http://dx.doi.org/10.1155/2010/743794
Clinical Study

The Abandoned Radical Hysterectomy for Cervical Cancer: Clinical Predictors and Outcomes

1Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA 98195, USA
2Department of Biostatistics, University of Washington, Seattle, WA 98195, USA
3Department of Obstetrics and Gynecology, University of Rochester School of Medicine, Rochester, NY 14642, USA
4Department of Radiation Oncology, University of Washington, Seattle, WA 98195, USA

Received 9 December 2009; Revised 1 February 2010; Accepted 10 February 2010

Academic Editor: Bradley J. Monk

Copyright © 2010 Heidi J. Gray et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objective. Cervical cancer patients who had an abandoned radical hysterectomy were evaluated for preoperative clinical predictors, complication rates, and outcomes. Study Design. IRB approval was obtained for this retrospective analysis and chart review was performed. Results. From 268 women with early-stage (IA2 to IIA) cervical cancer, 19 (7%) had an abandoned hysterectomy for finding grossly positive lymph nodes (84%) or pelvic spread of tumor (16%). No clinical characteristics clearly identified women preoperatively at risk of having an abandoned hysterectomy. In the abandoned group, 26% suffered major morbidities, compared to 34% in the completed group (OR 0.69, [CI 0 . 1 6 - 2 . 5 7 ], 𝑃 = . 7 8 9 ). Thirty-seven percent recurred in the abandoned group, compared to 18% in the completed group ( 𝑃 = . 1 6 8 ). Overall survival in the abandoned group was 73% versus 80% in the completed group ( 𝑃 = . 7 7 2 ). Conclusion. The practice of abandoning a planned radical hysterectomy for unexpected metastatic disease may not worsen the outcome.